These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 9795871)
1. Normal growth in the short normal prepubertal child: the Wessex Growth Study. Voss LD; Mulligan J J Med Screen; 1998; 5(3):127-30. PubMed ID: 9795871 [TBL] [Abstract][Full Text] [Related]
4. Short stature at school entry--an index of social deprivation? (The Wessex Growth Study). Voss LD; Mulligan J; Betts PR Child Care Health Dev; 1998 Mar; 24(2):145-56. PubMed ID: 9544443 [TBL] [Abstract][Full Text] [Related]
5. Poor growth in school entrants as an index of organic disease: the Wessex growth study. Voss LD; Mulligan J; Betts PR; Wilkin TJ BMJ; 1992 Dec; 305(6866):1400-2. PubMed ID: 1486305 [TBL] [Abstract][Full Text] [Related]
6. The potential effect of the UK 1990 height centile charts on community growth surveillance. Cotterill AM; Majrowski WH; Hearn S; Jenkins S; Preece MA; Savage MO Arch Dis Child; 1996 May; 74(5):452-4. PubMed ID: 8669965 [TBL] [Abstract][Full Text] [Related]
7. The relationship between stature, growth, and short-term changes in height and weight in normal prepubertal children. Tillmann V; Thalange NK; Foster PJ; Gill MS; Price DA; Clayton PE Pediatr Res; 1998 Dec; 44(6):882-6. PubMed ID: 9853922 [TBL] [Abstract][Full Text] [Related]
8. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years. de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379 [TBL] [Abstract][Full Text] [Related]
9. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature. Lampit M; Hochberg Z J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial. Blum WF; Crowe BJ; Quigley CA; Jung H; Cao D; Ross JL; Braun L; Rappold G; J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016 [TBL] [Abstract][Full Text] [Related]
11. Growth charts, growth velocity and bone development in childhood obesity. De Simone M; Farello G; Palumbo M; Gentile T; Ciuffreda M; Olioso P; Cinque M; De Matteis F Int J Obes Relat Metab Disord; 1995 Dec; 19(12):851-7. PubMed ID: 8963351 [TBL] [Abstract][Full Text] [Related]
12. Are short normal children at a disadvantage? The Wessex growth study. Downie AB; Mulligan J; Stratford RJ; Betts PR; Voss LD BMJ; 1997 Jan; 314(7074):97-100. PubMed ID: 9006466 [TBL] [Abstract][Full Text] [Related]
13. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153 [TBL] [Abstract][Full Text] [Related]
14. The reliability of height and height velocity in the assessment of growth (the Wessex Growth Study). Voss LD; Wilkin TJ; Bailey BJ; Betts PR Arch Dis Child; 1991 Jul; 66(7):833-7. PubMed ID: 1863094 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature. Kriström B; Aronson AS; Dahlgren J; Gustafsson J; Halldin M; Ivarsson SA; Nilsson NO; Svensson J; Tuvemo T; Albertsson-Wikland K J Clin Endocrinol Metab; 2009 Feb; 94(2):483-90. PubMed ID: 19001519 [TBL] [Abstract][Full Text] [Related]
16. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment. Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566 [TBL] [Abstract][Full Text] [Related]
18. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment. Fjellestad-Paulsen A; Simon D; Czernichow P J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children. Boguszewski M; Rosberg S; Albertsson-Wikland K J Clin Endocrinol Metab; 1995 Sep; 80(9):2599-606. PubMed ID: 7673401 [TBL] [Abstract][Full Text] [Related]
20. Effect of growth hormone treatment on the adult height of children with chronic renal failure. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Haffner D; Schaefer F; Nissel R; Wühl E; Tönshoff B; Mehls O N Engl J Med; 2000 Sep; 343(13):923-30. PubMed ID: 11006368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]